Zhuzhou Qianjin Pharmaceutical (600479.SH) subsidiary obtains drug registration certificate.
Qianjin Pharmaceutical Co., Ltd. (600479.SH) announced that recently, its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. (referred to as "Qianjin Xiangjiang Pharmaceutical") and Hunan Qianjin Qieli Pharmaceutical Co., Ltd. (referred to as "Qianjin Qieli Pharmaceutical") received the "Drug Registration Certificates" approved and issued by the National Medical Products Administration for Minoxidil Solution, Ezetimibe Tablets, Amlodipine Benazepril Capsules, and Ursodeoxycholic Acid Capsules.
Zhuzhou Qianjin Pharmaceutical (600479.SH) announced that its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. (hereinafter referred to as Qianjin Xiangjiang Pharmaceutical) and Hunan Qianjin Qieli Pharmaceutical Co., Ltd. (hereinafter referred to as Qianjin Qieli Pharmaceutical) have received the Drug Registration Certificates for Minoxidil lotion, Ezetimibe tablets, Amlodipine Benazepril capsules, and Ursodeoxycholic acid capsules approved by the National Medical Products Administration.
The acquisition of these drug registration certificates further enriches the companys product pipeline and is beneficial to the companys sustainable development.
Related Articles
YOUZAN (06051) repurchased 700,000 shares on August 17 at a cost of HKD 915,500.
SINOPEC SSC (01033) announced its interim results, reporting a net profit attributable to shareholders of 510 million yuan, a year-on-year increase of 3.5%.
MILLIONHOPE IND (01897) spent HKD 50,000 on August 17 to repurchase 100,000 shares.
YOUZAN (06051) repurchased 700,000 shares on August 17 at a cost of HKD 915,500.
SINOPEC SSC (01033) announced its interim results, reporting a net profit attributable to shareholders of 510 million yuan, a year-on-year increase of 3.5%.
MILLIONHOPE IND (01897) spent HKD 50,000 on August 17 to repurchase 100,000 shares.
RECOMMEND
